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Epidemics of community-acquired Staphylococcus aureus are caused by strains producing high concentra-
tions of phenol-soluble modulins (PSMs). How neutrophils sense PSMs is revealed in this issue ofCell Host &
Microbe. Such interactions are key to infection outcome and may be the basis for development of new treat-
ment strategies.Upon colonizing a new host, an infectious
agent must be able to resist, subvert, or
escape the action of the immune system
in order for the agent to remain within
the host. Many microorganisms are able
to do this without causing disease, but
some are pathogenic by virtue of their
successful evasion of innate defenses,
such as antimicrobial peptides and killing
by phagocytic leukocytes. It is the
balance struck between host response
and pathogen countermeasures that
determines the severity of disease.
A ubiquitous member of the normal
human microflora, the Gram-positive
bacterium Staphylococcus aureus is a
significant cause of human morbidity
and mortality. Colonization can occur in
community or healthcare settings, and
infections are often difficult to treat
because of widespread antibiotic resis-
tance; methicillin-resistant S. aureus
(MRSA) strains are common. Individuals
who succumb to healthcare-associated
strains (HA-MRSA) usually have predis-
posing risk factors, but community-asso-
ciated infections (CA-MRSA) can occur in
otherwise healthy individuals who are
neither predisposed to infection nor
exposed to any healthcare setting, sug-
gesting that these strains are more viru-
lent than HA-MRSA. Indeed, interest in
CA-MRSA infections has grown over the
past decade because of its epidemic
spread throughout much of the devel-
oped world, which has further increased
the total global burden of S. aureus
disease (Graves et al., 2010). Most
CA-MRSA diseases are of skin and soft
tissue and are similar to those caused by
methicillin-sensitive S. aureus; however,
these strains also have the ability to cause
severe invasive diseases such as pneu-monia, myositis, and necrotising fasciitis.
Regardless of severity, disease is due, in
large part, to the ability of the pathogen
to evade host innate immunity. CA-
MRSA pathologies are often character-
ized by influx of neutrophils at the site of
infection, their subsequent lysis, and
concomitant tissue damage (Graves
et al., 2010).
S. aureus can produce a range of
toxins, one of which, Panton-Valentine
leukocidin (PVL), has been linked with
CA-MRSA and is the subject of intensive
study. In experiments to determine its
role as a virulence factor in animal models
of S. aureus disease, mixed results have
been obtained (Graves et al., 2010).
Furthermore, there are reports of CA-
MRSA strains that lack PVL (Zhang
et al., 2008), suggesting that the molec-
ular basis for the enhanced virulence in
these strains cannot be explained solely
by the presence of this toxin. S. aureus
also produces several small (c. 20 amino
acid) phenol-soluble modulin (PSM)
peptides that efficiently destroy host
neutrophils at micromolar concentrations
in vitro, most probably by disruption of
cell membranes. Seven of these PSMs
are encoded by the core genome of S.
aureus, with one more sometimes being
found on a mobile genetic element found
in HA-MRSA strains (Wang et al., 2007;
Queck et al., 2009). Relative to other S.
aureus strains, CA-MRSA produce much
higher concentrations of PSMs, and it is
this difference that accounts, at least in
part, for their potent virulence (Wang
et al., 2007). These small a-helical amphi-
pathic peptides carry an N-terminal
N-formyl methionine, which is detected
by the host immune system as a signal
for bacterial infection, as only prokaryotesCell Host & Microbcommence protein biosynthesis with a
formyl methionine (Fu et al., 2006). In
addition to their cytolytic activity, PSMs
have powerful chemoattractant proper-
ties, which accounts for the leukocyte
influx observed in CA-MRSA disease.
Formyl peptide receptors found on
neutrophils are part of the G protein-
coupled receptor superfamily and are
responsible for sensing PSMs and elicit-
ing cell migration. It is the molecular basis
of this recognition that is addressed by
Kretschmer et al. (2010) in this issue of
Cell Host & Microbe.
Dorothee Kretschmer and Anne-
Katherine Gleske from Andreas Peschel’s
laboratory have, along with colleagues,
discovered that the human formyl peptide
receptor 2 (FPR2/ALX) present on neutro-
phils is able to sense PSMs at nanomolar
concentrations and initiate the proinflam-
matory response characteristic of much
CA-MRSA disease. Of interest, S. aureus
subverts signaling via formyl peptide
receptors in more than one way. The
anti-inflammatory chemotaxis inhibitory
protein of S. aureus (CHIPS) blocks pep-
tide recognition by formyl peptide
receptor 1 (FPR1) (de Haas et al., 2004).
The pathogen also produces an anti-
inflammatory antagonist of FPR2/ALX,
known as FPR2/ALX inhibitory protein
(FLIPr), which impairs neutrophil re-
sponses to FPR2/ALX agonists and
FPR1 agonists at high concentrations
(Prat et al., 2006). Furthermore, a peptide
called FLIPr-like has recently been identi-
fied, which is a potent inhibitor of both
FPR1- and FPR2/ALX-mediated neutro-
phil activation (Prat et al., 2009). Given
the lengths that S. aureus appears to go
to in order to suppress signaling through
formyl peptide receptors, we could bee 7, June 17, 2010 ª2010 Elsevier Inc. 423
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these signaling events would increase
the pathogenic potential of S. aureus,
and, in many strains, that is indeed what
happens. But Kretschmer et al. (2010)
have demonstrated that PSMs activate
cells by signaling specifically through
FPR2/ALX, causing influx of neutrophils
at the site of infection, where they are
then lysed, presumably by higher local
concentrations of PSMs. How S. aureus
ensures appropriate expression of these
antagonists relative to PSMs remains to
be elucidated. It is noteworthy that
FPR2/ALX appears to play no part in
PSM cytotoxicity (Kretschmer et al.,
2010). Clearly, the success of CA-MRSA
strains is linked to their ability to produce
relatively large concentrations of PSMs,
which, in turn, have the ability to attract
phagocytic neutrophils (Wang et al.,
2007; Kretschmer et al., 2010). However,
these cells are unable to destroy the
invading S. aureus and eradicate the
infection because of the other edge to
this PSM sword, namely a powerful cyto-
lytic activity that can destroy those
incoming immune cells. Associated with
this activity is extensive tissue destruc-424 Cell Host & Microbe 7, June 17, 2010 ª2tion, which is presumably advantageous
to S. aureus.
These interesting findings need to be
viewed in a wider context of recognition
of S. aureus by the immune system. The
human host employs an array of sensor
mechanisms in order to recognize a spec-
trum of bacterial components. In addition
to being recognized by formyl peptide
receptors, PSMs (albeit from Staphylo-
coccus epidermidis) have been reported
to activate human cells through Toll-like
receptors 2 (Hajjar et al., 2001). It thus
seems possible that the pathogen manip-
ulates multiple host cell signaling path-
ways with a single molecule to mediate
CA-MRSA disease. It is through such
understanding of the dynamics of host-
pathogen interactions that we may be
able to develop novel strategies for inter-
vention and treatment of debilitating
bacterial diseases such as CA-MRSA.REFERENCES
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Viruses are perfect opportunists that have evolved to modify numerous cellular processes in order to
complete their replication cycle in the host cell. An article by Reggiori and coworkers in this issue of Cell
Host & Microbe reveals how coronaviruses can divert a cellular quality control pathway that normally func-
tions in degradation of mis-folded proteins to replicate the viral genome.Asobligatory intracellularparasites,viruses
mayuse every component andmechanism
of the cell in order to produce infectious
progeny. Virtually every step of a viral repli-
cation cycle occurs in close association
with cellularmembranes, the cytoskeleton,
membrane trafficking, or signaling path-
ways. Given their total dependence on
host cells, it is not surprising that viruseshaveevolved tomodifycells to their benefit.
Particularly interesting in this respect is that
viruses may exploit the cellular defense
mechanisms that are induced in response
to infection and that are aimed at destroy-
ing invading pathogens.
Viruses with a RNA genome of plus-
stranded polarity without exception repli-
cate their RNA in the host cytoplasm.For those that have been studied at the
ultrastructural level, genome replication
seems to be accompanied by the induc-
tion of membrane proliferations. These
membranes are thought to serve as scaf-
folds for the viral replication translation
complexes (RTCs) and to protect newly
synthesized viral RNA (Miller and Krijnse-
Locker, 2008). At the ultrastructural level,
